Associate Director, Medical Strategy & Operations Lead - Rare Disease (US Medical Affairs)

About This Role The Associate Director, Medical Strategy & Operations (S&O) Lead is a strategic operations leader within North America (NA) Medical Affairs and a core member of Rare Disease LT.   The role drives strategy-to-execution integration, enterprise alignment, and coordination of governance processes and operating rhythm across Biogen North America. The role partners closely with the Head of Rare Disease and Medical leadership team to help advance strategic integration across Medical leadership, Field teams, Medical Excellence, Operations, Global Medical, and Biogen North America stakeholders (including Commercial and Market Access). The role identifies opportunities and supports alignment between BNA enterprise priorities and NA Medical strategy and helps ensure clarity, coordinated execution, and effective flow of information and decisions across functions. The S&O Lead supports the design and maintenance of governance, alignment, and operating structures that pull through strategy to enable coordinated execution across functions. This includes clarifying decision rights, ensuring appropriate ownership, and maintaining visibility of priorities and performance across the Therapeutic Area. The role plays an important part in advancing the Medical S&O function’s strategic integrator model, helping connect strategy, governance, and execution across the Therapeutic Area while building toward broader enterprise leadership responsibilities. What You’ll Do Serve as a strategic thought partner to the Head of Rare Disease and Medical leadership team, supporting the identification of execution risks, operational challenges, and opportunities for alignment. Drive and facilitate the integration of strategy-to-execution planning across planning cycles (AOP, ICP, long-range planning), helping translate strategic priorities into coordinated execution plans and measurable milestones. Drive and coordinate the operating rhythm for the Rare Disease Medical team, including milestone tracking, governance forums, KPI integration, and preparation for leadership reviews. Partner with cross-functional stakeholders to ensure Medical priorities and activities are appropriately represented within the broader BNA operating cadence. Facilitate effective information flow and strategic communication across Medical leadership, enterprise partners, and key governance forums. Develop and support preparation of executive materials and strategic narratives that communicate Medical priorities, progress, risks, and key decisions for leadership audiences. Partner with Finance and medical Rare Disease LT to lead budget planning, monitoring, and performance tracking for the Therapeutic Area. Help identify execution risks, structural barriers, and cross-functional dependencies, facilitating alignment and resolution with appropriate stakeholders. Support coordination between NA Medical and Global Medical teams to ensure alignment across strategic initiatives and key workstreams. Contribute to continuous improvement initiatives that enhance operating clarity, governance effectiveness, and enterprise collaboration. Promote a culture of accountability, transparency, and cross-functional partnership within the Therapeutic Area and broader Medical organization.

You are a strategic leader who operates effectively at the intersection of strategy, governance, and execution in a complex matrixed organization. You are comfortable navigating ambiguity, influencing stakeholders without formal authority, and helping drive alignment across cross-functional teams. You combine strong business acumen, financial discipline, and operational rigor with clear communication and structured problem-solving. You balance enterprise perspective with Medical integrity and scientific rigor.

BA/BS required; advanced degree (MBA, MS, PhD) preferred. 7+ years of pharmaceutical/biotech industry experience required. 7+ years of relevant experience in